ESTRELLA IMMUNOPHARMA, INC. (ESLA) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading ESLA…

ESTRELLA IMMUNOPHARMA, INC. (ESLA) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

ESTRELLA IMMUNOPHARMA, INC.

ESLA · CIK 1844417

4 · Aug 26, 2026 · Director, CEO Liu Cheng exercised options for 200K shares

4

Director, CEO Liu Cheng exercised options for 200K shares

Filed: Aug 26, 2026
Period: Aug 25, 2026
Accession: 0001996255-26-000004
Filer: Estrella Immunopharma, Inc.

View on SEC.gov All SEC filings

Filing document

PRIMARY DOCUMENT

xslF345X06/primary_doc.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4PRIMARY DOCUMENTprimary_doc.xml
Open SEC.gov